ストックスクリーナーアプリを入手
15.04
4.52%
-0.23
前日終値:
$15.27
開ける：
$15.27
24時間の取引高:
3,585
Relative Volume:
0.05
時価総額：
$191.78M
収益：
-
当期純損益:
$-31.48M
株価収益率:
-14.46
EPS:
-1.04
ネットキャッシュフロー:
$-28.71M
1週間 パフォーマンス:
+1.04%
1か月 パフォーマンス:
+38.07%
6か月 パフォーマンス:
+177.71%
1年 パフォーマンス:
+220.44%
1日の値動き範囲:
$14.95
$15.44
1週間の範囲:
$13.76
$15.44
52週間の値動き範囲:
$4.11
$28.68
Forte Biosciences Inc Stock (FBRX) Company Profile
名前
Forte Biosciences Inc
セクター
電話
(310) 618-6994
住所
3060 PEGASUS PARK DRIVE, DALLAS, CA
FBRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
FBRX
Forte Biosciences Inc
|
15.43 | 189.85M | 0 | -31.48M | -28.71M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.75 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
549.47 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
800.40 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.18 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-18 | 開始されました | Guggenheim | Buy |
| 2025-01-21 | 開始されました | TD Cowen | Buy |
| 2024-04-08 | アップグレード | Ladenburg Thalmann | Neutral → Buy |
| 2021-09-20 | アップグレード | Chardan Capital Markets | Sell → Buy |
| 2021-09-03 | ダウングレード | B. Riley Securities | Buy → Neutral |
| 2021-09-03 | ダウングレード | Chardan Capital Markets | Buy → Sell |
| 2021-09-03 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2021-09-03 | ダウングレード | Truist | Buy → Hold |
| 2021-05-14 | 開始されました | B. Riley Securities | Buy |
| 2021-03-26 | 開始されました | Citigroup | Buy |
| 2020-08-28 | アップグレード | Chardan Capital Markets | Neutral → Buy |
| 2020-08-25 | 開始されました | Truist | Buy |
すべてを表示
Forte Biosciences Inc (FBRX) 最新ニュース
Why Forte Biosciences Inc. stock is a value investor pick2025 Price Momentum & Scalable Portfolio Growth Ideas - newser.com
Forecasting Forte Biosciences Inc. price range with options data2025 Support & Resistance & Safe Entry Zone Tips - newser.com
What institutional flow reveals about Forte Biosciences Inc.GDP Growth & Daily Entry Point Trade Alerts - newser.com
Is Forte Biosciences Inc. stock entering bullish territoryPortfolio Profit Report & Fast Gain Swing Alerts - newser.com
How to read the order book for Forte Biosciences Inc.Trade Risk Summary & Community Shared Stock Ideas - newser.com
Forte Biosciences Inc. stock prediction for this weekGap Down & Comprehensive Market Scan Reports - newser.com
Chart based analysis of Forte Biosciences Inc. trendsOil Prices & AI Driven Price Forecasts - newser.com
What makes Forte Biosciences Inc. (37T) stock appealing to growth investors2025 Market Trends & Real-Time Buy Zone Alerts - newser.com
Is Forte Biosciences Inc. building a consolidation baseInsider Selling & Daily Chart Pattern Signal Reports - newser.com
Forte Biosciences (NASDAQ:FBRX) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat
Forte Biosciences Inc. Reports Inducement Grants Under Nasdaq Listing Rules - MarketScreener
Can a trend reversal in Forte Biosciences Inc. lead to recoveryTrend Reversal & Weekly High Conviction Ideas - newser.com
Will Forte Biosciences Inc. continue its uptrendDollar Strength & Fast Moving Stock Trade Plans - newser.com
Forte Biosciences reports inducement grants under Nasdaq listing rules - MarketScreener
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules - MarketScreener
Will Forte Biosciences Inc. (37T) stock outperform Dow JonesTrade Performance Summary & Free Low Drawdown Momentum Trade Ideas - newser.com
Forte Biosciences Sees Unusually High Options Volume (NASDAQ:FBRX) - MarketBeat
How to build a dashboard for Forte Biosciences Inc. stock2025 Technical Overview & Accurate Entry and Exit Point Alerts - newser.com
Forte Biosciences (FBRX) Price Target Increased by 16.98% to 53.30 - Nasdaq
What to do if you’re stuck in Forte Biosciences Inc.2025 Institutional Moves & Long Hold Capital Preservation Plans - newser.com
Can ACE Edutrend Limited Maintain Its Growth Rate as a Small CapPrice Volatility Patterns & 100% Free Stock Analysis for Smarter Decisions - earlytimes.in
Forte Biosciences Inc (FBRX) 財務データ
収益
当期純利益
現金流量
EPS
Forte Biosciences Inc (FBRX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Wagner Paul A. | SEE REMARKS |
Oct 01 '25 |
Option Exercise |
0.00 |
1,250 |
0 |
82,190 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Jul 01 '25 |
Option Exercise |
0.00 |
375 |
0 |
31,733 |
| Wagner Paul A. | SEE REMARKS |
Jul 01 '25 |
Option Exercise |
0.00 |
1,250 |
0 |
81,038 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Apr 01 '25 |
Option Exercise |
0.00 |
375 |
0 |
31,372 |
| Wagner Paul A. | SEE REMARKS |
Apr 01 '25 |
Option Exercise |
0.00 |
1,250 |
0 |
79,806 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Jan 01 '25 |
Option Exercise |
0.00 |
375 |
0 |
31,151 |
| Wagner Paul A. | SEE REMARKS |
Jan 01 '25 |
Option Exercise |
0.00 |
1,250 |
0 |
78,720 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Nov 21 '24 |
Buy |
5.55 |
22,514 |
124,998 |
30,776 |
0.21%
2.95%
大文字化:
|
ボリューム (24 時間):